RAZOBIN

This brand name is authorized in South Africa.

Active ingredients

The drug RAZOBIN contains a combination of these active pharmaceutical ingredients (APIs):

1	Piperacillin UNII M98T69Q7HP - PIPERACILLIN SODIUM
	Piperacillin is a broad-spectrum, semisynthetic penicillin. Piperacillin exerts bactericidal activity by inhibition of both septum and cell-wall synthesis.
	Read more about Piperacillin
2	Tazobactam UNII UXA545ABTT - TAZOBACTAM SODIUM
	Tazobactam is a beta-lactam structurally related to penicillins. It is an inhibitor of many molecular Class A beta-lactamases, including CTX-M, SHV, and TEM enzymes.
	Read more about Tazobactam

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RAZOBIN Powder for solution for injection/infusion	MPI, Generic	Health Products Regulatory Authority (ZA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CA12	Piperacillin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CA Penicillins with extended spectrum
Discover more medicines within J01CA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ZA	Health Products Regulatory Authority	44/20.1.1/0080, 44/20.1.1/0081, 44/20.1.1/0082